UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 181

Sortiert nach

A phase I trial of taxol given by a 6-hour intravenous infusion

Journal of clinical oncology, 1991-07, Vol.9 (7), p.1261-1267

1991

Link zum Volltext

Verfügbarkeit prüfen

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Annals of oncology, 2003-09, Vol.14 (9), p.1399-1405

2003

Link zum Volltext

Verfügbarkeit prüfen

High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects

Journal of clinical oncology, 1989-08, Vol.7 (8), p.1093-1098

1989

Link zum Volltext

Verfügbarkeit prüfen

Is diabetes mellitus (DM) associated with worse outcomes in pancreatic cancer (PC)?

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4114-4114

2010

Link zum Volltext

Verfügbarkeit prüfen

Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy

The American journal of clinical nutrition, 1997-05, Vol.65 (5), p.1495-1501

1997

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

European journal of cancer (1990), 1994, Vol.30 (3), p.417-418

1994

Link zum Volltext

Verfügbarkeit prüfen

Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer

Cancer chemotherapy and pharmacology, 1999, Vol.43 (1), p.68-72

1999

Link zum Volltext

Verfügbarkeit prüfen

Etoposide in gastric cancer

Seminars in oncology, 1992-12, Vol.19 (6), p.59-62

1992

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical investigation of amonafide

Journal of clinical oncology, 1989-09, Vol.7 (9), p.1351-1358

1989

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical and pharmacokinetic trial of flavone acetic acid

JNCI : Journal of the National Cancer Institute, 1991-01, Vol.83 (2), p.124-128

1991

Link zum Volltext

Verfügbarkeit prüfen

Trajectory of cognitive impairment during breast cancer treatment: A prospective analysis

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.8500-8500

2006

Link zum Volltext

Verfügbarkeit prüfen

A phase I/phase II trial of granulocyte colony-stimulating factor as bone marrow support in patients treated with vinorelbine (navelbine) : study design and goals

Seminars in oncology, 1995-04, Vol.22 (2), p.38-40

HAVLIN, K

1995

Link zum Volltext

Verfügbarkeit prüfen

Prechemotherapy hemoglobin (Hgb) and cognitive impairment among breast cancer patients

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8124-8124

2005

Link zum Volltext

Verfügbarkeit prüfen

Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study

Anti-cancer drugs, 1995-04, Vol.6 (2), p.229-236

1995

Link zum Volltext

Verfügbarkeit prüfen

Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule

Cancer research (Chicago, Ill.), 1990-12, Vol.50 (23), p.7496-7500

1990

Link zum Volltext

Verfügbarkeit prüfen

Performance of cognitively impaired oncology patients and normal controls on functional MRI tasks

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8023-8023

2004

Link zum Volltext

Verfügbarkeit prüfen

Performance of cognitively impaired oncology patients and normal controls on functional MRI tasks

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.8023-8023

2004

Link zum Volltext

Verfügbarkeit prüfen

Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer

The Journal of infusional chemotherapy, 1996, Vol.6 (4), p.211

1996

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule

Anti-cancer drugs, 1994-04, Vol.5 (2), p.151-159

1994

Link zum Volltext

Verfügbarkeit prüfen

A phase I clinical and pharmacokinetic trial of hepsulfam

Cancer research (Chicago, Ill.), 1991-12, Vol.51 (23), p.6268-6272

1991

Link zum Volltext

Verfügbarkeit prüfen

Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators

Anti-cancer drugs, 1991-08, Vol.2 (4), p.357

1991

Link zum Volltext

Verfügbarkeit prüfen

Aminoglutethimide: theoretical considerations and clinical results in advanced prostate cancer

Cancer treatment and research, 1988, Vol.39, p.83

1988

Link zum Volltext

Verfügbarkeit prüfen

A phase I trial of trimetrexate (NSC352122) on a daily x 5 schedule in patients with refractory adult leukemia

Anti-cancer drugs, 1993-04, Vol.4 (2), p.163

1993

Link zum Volltext

Verfügbarkeit prüfen

High‐dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study

Cancer, 1989-02, Vol.63 (3), p.423-427

1989

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(160)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(121)
Humans
(70)
Physical Sciences
(64)
Physics
(56)
Life Sciences & Biomedicine
(49)
Biological And Medical Sciences
(34)
Physics, Multidisciplinary
(34)
Female
(31)
Male
(27)
Space Life Sciences
(26)
Middle Aged
(24)
Adult
(21)
Fundamental And Applied Biological Sciences. Psychology
(19)
Oncology
(18)
Aged
(17)
Exact Sciences And Technology
(17)
Fractals
(17)
Life Sciences
(17)
Animals
(16)
Medical Sciences
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

A phase I trial of taxol given by a 6-hour intravenous infusion

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects

Is diabetes mellitus (DM) associated with worse outcomes in pancreatic cancer (PC)?

Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer

Etoposide in gastric cancer

Phase I clinical investigation of amonafide

Phase I clinical and pharmacokinetic trial of flavone acetic acid

Trajectory of cognitive impairment during breast cancer treatment: A prospective analysis

A phase I/phase II trial of granulocyte colony-stimulating factor as bone marrow support in patients treated with vinorelbine (navelbine) : study design and goals

Prechemotherapy hemoglobin (Hgb) and cognitive impairment among breast cancer patients

Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study

Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule

Performance of cognitively impaired oncology patients and normal controls on functional MRI tasks

Performance of cognitively impaired oncology patients and normal controls on functional MRI tasks

Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer

Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule

A phase I clinical and pharmacokinetic trial of hepsulfam

Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators

Aminoglutethimide: theoretical considerations and clinical results in advanced prostate cancer

A phase I trial of trimetrexate (NSC352122) on a daily x 5 schedule in patients with refractory adult leukemia

High‐dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study

Suchergebnisse filtern